BzATP
Prototypic P2X7 receptor agonist
Product Specifications
Background
BzATP triethylammonium salt is a prototypic P2X7 receptor agonist that exhibits 5 - 10 fold greater potency than ATP. This small molecule also exhibits partial agonist activity at P2X1 and P2Y1 receptors. Lastly, it can be used as a photoaffinity label for ATPase.
CAS Number
112898-15-4
Product Name Alternative
2' (3') -O- (4-Benzoylbenzoyl) adenosine-5'-triphosphate tri (triethylammonium) salt
UNSPSC
41116105
Type
Agonist
Source
Synthetic
Field of Research
Neuroscience | Ion Channels
Purity
>97.7%
Weight
0.005
Format
Off white solid
Solubility
Soluble in water.
Molecular Formula
C24H24N5O15P3•C18H45N3
Molecular Weight
1018.97
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
References & Citations
1. Young M., Pelegrin P., & Surprenant A. (2007) Mol Pharmacol. 92-100.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680898-500 1x 500 µL
GFAP (GA-5 + ASTRO/789), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
HP218910 200 Reactions
NHEDC2 (SLC9B2) Human qPCR Primer Pair (NM_178833)
Sign In for Pricing
View Details 
BNC682807-100 1x 100 µL
Calretinin / Calbindin 2 (Mesothelioma Marker) (CALB2/2807), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
